论文信息 - Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG) - 字舞流文

Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)

V. Tjan-Heijnen | F. Erdkamp | M. Bos | L. V. van Warmerdam | M. López-Yurda | H. de Graaf | J. Rademaker-Lakhai | A. Honkoop | A. K. M. Claessens | J. Bouma | M. V. D. van der Sangen | Edith van Druten | M. Lopez-Yurda | A. K. Claessens